910 related articles for article (PubMed ID: 16618833)
21. Dehydroepiandrosterone mimics acute actions of insulin to stimulate production of both nitric oxide and endothelin 1 via distinct phosphatidylinositol 3-kinase- and mitogen-activated protein kinase-dependent pathways in vascular endothelium.
Formoso G; Chen H; Kim JA; Montagnani M; Consoli A; Quon MJ
Mol Endocrinol; 2006 May; 20(5):1153-63. PubMed ID: 16373398
[TBL] [Abstract][Full Text] [Related]
22. Insulin resistance, metabolic syndrome and endothelial dysfunction.
Bigazzi R; Bianchi S
J Nephrol; 2007; 20(1):10-4. PubMed ID: 17347967
[TBL] [Abstract][Full Text] [Related]
23. Effects of insulin resistance on endothelial progenitor cells and vascular repair.
Cubbon RM; Kahn MB; Wheatcroft SB
Clin Sci (Lond); 2009 Aug; 117(5):173-90. PubMed ID: 19630751
[TBL] [Abstract][Full Text] [Related]
24. Review article: diabetes and atherosclerosis--running on a common road.
Federici M; Lauro R
Aliment Pharmacol Ther; 2005 Nov; 22 Suppl 2():11-5. PubMed ID: 16225464
[TBL] [Abstract][Full Text] [Related]
25. Vascular actions of insulin with implications for endothelial dysfunction.
Potenza MA; Addabbo F; Montagnani M
Am J Physiol Endocrinol Metab; 2009 Sep; 297(3):E568-77. PubMed ID: 19491294
[TBL] [Abstract][Full Text] [Related]
26. Molecular and physiologic actions of insulin related to production of nitric oxide in vascular endothelium.
Vincent MA; Montagnani M; Quon MJ
Curr Diab Rep; 2003 Aug; 3(4):279-88. PubMed ID: 12866989
[TBL] [Abstract][Full Text] [Related]
27. The role of insulin resistance in the pathogenesis of atherosclerotic cardiovascular disease: an updated review.
Reddy KJ; Singh M; Bangit JR; Batsell RR
J Cardiovasc Med (Hagerstown); 2010 Sep; 11(9):633-47. PubMed ID: 20164784
[TBL] [Abstract][Full Text] [Related]
28. The dipeptidyl peptidase-4 inhibitor teneligliptin improved endothelial dysfunction and insulin resistance in the SHR/NDmcr-cp rat model of metabolic syndrome.
Nakagami H; Pang Z; Shimosato T; Moritani T; Kurinami H; Koriyama H; Tenma A; Shimamura M; Morishita R
Hypertens Res; 2014 Jul; 37(7):629-35. PubMed ID: 24621463
[TBL] [Abstract][Full Text] [Related]
29. Insulin Resistance and Endothelial Dysfunction Constitute a Common Therapeutic Target in Cardiometabolic Disorders.
Janus A; Szahidewicz-Krupska E; Mazur G; Doroszko A
Mediators Inflamm; 2016; 2016():3634948. PubMed ID: 27413253
[TBL] [Abstract][Full Text] [Related]
30. Cocoa, glucose tolerance, and insulin signaling: cardiometabolic protection.
Grassi D; Desideri G; Mai F; Martella L; De Feo M; Soddu D; Fellini E; Veneri M; Stamerra CA; Ferri C
J Agric Food Chem; 2015 Nov; 63(45):9919-26. PubMed ID: 26126077
[TBL] [Abstract][Full Text] [Related]
31. In utero origins of adult insulin resistance and vascular dysfunction.
Thompson JA; Regnault TR
Semin Reprod Med; 2011 May; 29(3):211-24. PubMed ID: 21710397
[TBL] [Abstract][Full Text] [Related]
32. Role of insulin resistance in endothelial dysfunction.
Muniyappa R; Sowers JR
Rev Endocr Metab Disord; 2013 Mar; 14(1):5-12. PubMed ID: 23306778
[TBL] [Abstract][Full Text] [Related]
33. Antiatherosclerotic and anti-insulin resistance effects of adiponectin: basic and clinical studies.
Han SH; Sakuma I; Shin EK; Koh KK
Prog Cardiovasc Dis; 2009; 52(2):126-40. PubMed ID: 19732605
[TBL] [Abstract][Full Text] [Related]
34. Insulin resistance, metabolic syndrome and vascular diseases: update on mechanistic linkages.
Lteif A; Mather K
Can J Cardiol; 2004 Aug; 20 Suppl B():66B-76B. PubMed ID: 15309208
[TBL] [Abstract][Full Text] [Related]
35. New concepts in extracellular signaling for insulin action: the single gateway hypothesis.
Bergman RN
Recent Prog Horm Res; 1997; 52():359-85; discussion 385-7. PubMed ID: 9238859
[TBL] [Abstract][Full Text] [Related]
36. Uric acid induces endothelial dysfunction by vascular insulin resistance associated with the impairment of nitric oxide synthesis.
Choi YJ; Yoon Y; Lee KY; Hien TT; Kang KW; Kim KC; Lee J; Lee MY; Lee SM; Kang DH; Lee BH
FASEB J; 2014 Jul; 28(7):3197-204. PubMed ID: 24652948
[TBL] [Abstract][Full Text] [Related]
37. The insulin resistance syndrome: mechanisms of clustering of cardiovascular risk.
Chan JC; Tong PC; Critchley JA
Semin Vasc Med; 2002 Feb; 2(1):45-57. PubMed ID: 16222595
[TBL] [Abstract][Full Text] [Related]
38. Diabetes is a vascular disease: the role of endothelial dysfunction in pathophysiology of cardiovascular disease in diabetes.
Deedwania PC
Cardiol Clin; 2004 Nov; 22(4):505-9, v. PubMed ID: 15501619
[TBL] [Abstract][Full Text] [Related]
39. Endothelial dysfunction in obesity and insulin resistance: a road to diabetes and heart disease.
Caballero AE
Obes Res; 2003 Nov; 11(11):1278-89. PubMed ID: 14627747
[TBL] [Abstract][Full Text] [Related]
40. Insulin-induced vasodilatation and endothelial function in obesity/insulin resistance. Effects of troglitazone.
Tack CJ; Ong MK; Lutterman JA; Smits P
Diabetologia; 1998 May; 41(5):569-76. PubMed ID: 9628275
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
